Methods in molecular biology, Год журнала: 2025, Номер unknown, С. 101 - 146
Опубликована: Янв. 1, 2025
Язык: Английский
Methods in molecular biology, Год журнала: 2025, Номер unknown, С. 101 - 146
Опубликована: Янв. 1, 2025
Язык: Английский
Cell Death and Differentiation, Год журнала: 2023, Номер 30(10), С. 2201 - 2212
Опубликована: Авг. 26, 2023
Язык: Английский
Процитировано
22Journal of Cancer Research and Clinical Oncology, Год журнала: 2024, Номер 150(6)
Опубликована: Июнь 8, 2024
Spatial transcriptomics (ST) provides novel insights into the tumor microenvironment (TME). ST allows quantification and illustration of gene expression profiles in spatial context tissues, including both cancer cells which they are found. In research, has already provided metastasis, prognosis, immunotherapy responsiveness. The clinical precision oncology application next-generation sequencing (NGS) RNA profiling tumors relies on bulk methods that lack context. ability to preserve information is now possible, as it us capture heterogeneity multifocality. this narrative review, we summarize oncology, discuss clinic, review available research methods, seqFISH, MERFISH (Vizgen), CosMx SMI (NanoString), Xenium (10x), Visium Stereo-seq (STOmics), GeoMx DSP (NanoString). We then current literature with a focus solid organized by type. Finally, conclude addressing an important question: how will ultimately help patients cancer?
Язык: Английский
Процитировано
6Cell Death and Disease, Год журнала: 2024, Номер 15(8)
Опубликована: Авг. 7, 2024
Endometrial cancer (EC) is a highly heterogeneous malignancy characterized by varied pathology and prognoses, the heterogeneity of its cells tumor microenvironment (TME) remains poorly understood. We conducted single-cell RNA sequencing (scRNA-seq) on 18 EC samples, encompassing various pathological types to delineate their specific unique transcriptional landscapes. Cancer from diverse sources displayed distinct hallmarks labeled as immune-modulating, proliferation-modulating, metabolism-modulating in uterine clear cell carcinomas (UCCC), well-differentiated endometrioid endometrial (EEC-I), serous (USC), respectively. UCCC exhibited greatest heterogeneity. also identified potential effective drugs confirmed effectiveness using patient-derived organoids for each group. Regarding TME, we observed that prognostically favorable CD8
Язык: Английский
Процитировано
6Nature Cardiovascular Research, Год журнала: 2024, Номер 3(12), С. 1408 - 1423
Опубликована: Дек. 9, 2024
Язык: Английский
Процитировано
5Nature Genetics, Год журнала: 2023, Номер 55(11), С. 1792 - 1806
Опубликована: Окт. 30, 2023
Язык: Английский
Процитировано
12Discover Oncology, Год журнала: 2024, Номер 15(1)
Опубликована: Янв. 20, 2024
Язык: Английский
Процитировано
5Frontiers in Molecular Neuroscience, Год журнала: 2024, Номер 17
Опубликована: Апрель 4, 2024
Netrin-1 was initially discovered as a neuronal growth cue for axonal guidance, and its functions have later been identified in inflammation, tumorigenesis, neurodegeneration, other disorders. We recently found alterations the brains with Alzheimer’s disease, which might provide important clues to mechanisms of some unique pathologies. To better understanding this promising molecule, we here summarize research progresses genetics, pathology, biochemistry, cell biology studies about mechanistic roles biomarker potentials an emphasis on clinical neurodegenerative disorders order expand molecular player human diseases.
Язык: Английский
Процитировано
4Cancers, Год журнала: 2024, Номер 16(9), С. 1615 - 1615
Опубликована: Апрель 23, 2024
While RNA sequencing and multi-omic approaches have significantly advanced cancer diagnosis treatment, their limitation in preserving critical spatial information has been a notable drawback. This context is essential for understanding cellular interactions tissue dynamics. Multiplex digital profiling (MDSP) technologies overcome this by enabling the simultaneous analysis of transcriptome proteome data within intact architecture tissues. In breast research, MDSP emerged as promising tool, revealing complex biological questions related to disease evolution, identifying biomarkers, discovering drug targets. review highlights potential revolutionize clinical applications, ranging from risk assessment diagnostics prognostics, patient monitoring, customization treatment strategies, including trial guidance. We discuss major techniques, applications integration practice, addressing both current limitations. Emphasizing strategic use stratification women with benign disease, we also highlight its transformative reshaping landscape research treatment.
Язык: Английский
Процитировано
4Cancer and Metastasis Reviews, Год журнала: 2025, Номер 44(1)
Опубликована: Фев. 11, 2025
Язык: Английский
Процитировано
0Oncogene, Год журнала: 2025, Номер unknown
Опубликована: Май 2, 2025
Язык: Английский
Процитировано
0